XTLB TLV Week ended 31 Jul 2026

Weekly Investor Report

Name: XTLB weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

XTL Biopharmaceuticals Ltd. · Healthcare · Biotechnology

Open interactive chart View report data

Latest close 0.02 ILA

-4.8% latest week

Weekly setup

Mixed setup

The weekly trend is not active. Price is -8.8% below the Trend Line and sits at 3.0% of its 52-week range. The latest completed week returned -4.8%, after a 5.3% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 26 out of 100

Latest Close 0.02 ILA 31 Jul 2026

1W Return -4.8% latest completed week

4W Return 5.3% short-term follow-through

12W Return -4.8% quarterly tape

Trend Breadth 1.9% 1 of 52 weeks active

Volume Ratio 0.2x vs 13-week average

What is working

Activity pressure is positive on the latest completed week.

What could go wrong

The trend backdrop is inactive, so price action has not confirmed a constructive regime.
Price is below the Trend Line, which keeps downside pressure in focus.
Price is below Fair Value, so the market is still discounting the latest tape.
Next-week expectancy is negative at 33.24% based on similar historical setup states.

What to watch next

Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through -4.8% Latest completed week; four-week move 5.3%. Indicator stack 1/86 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 33.24% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 11 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -8.8% below the Trend Line and sits at 3.0% of its 52-week range. The latest completed week returned -4.8%, after a 5.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

0.02 ILA 3.0% 0.12 ILA

Range location3.0%Shows where the latest close sits between the 52-week low and high.

Trend distance-8.8%Price premium or discount versus the weekly Trend Line.

Fair-value gap-59.4%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-83.1%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.2x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1912-week average 0.17

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.19Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 5.3% over four weeks, -4.8% over 12 weeks, and -60.8% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-4.8%

4W5.3%

12W-4.8%

26W-25.9%

52W-60.8%

Active trend streak0 weeks

Active weeks in one year1

Trend breadth1.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure1.04Latest activity-pressure read.

Pressure change211.6%Four-week change in activity pressure.

Leadership-40.26Latest relative-leadership reading.

RS change17.9%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 11 relevant articles.

0 positive · 11 neutral · 0 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-83.1%Distance below the 52-week high.

13-week volatility9.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

6 Feb 6 Mar 3 Apr 1 May 29 May 26 Jun 31 Jul

Weeks higher7 of 2612 weeks finished lower.

Best week+55.0%Week of 1 May.

Worst week-32.3%Week of 8 May.

Latest week-4.8%Week of 31 Jul.

Shape of recent returns

Strong gains7

Modest gains0

Flat weeks7

Modest losses2

Sharp losses10

Recent vol9.6%13-week weekly-return volatility.

Base vol13.5%52-week weekly-return volatility.

Up/down split14/29Count of positive and negative weeks in the 52-week window.

Average skew13.8% / -8.4%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorIL Healthcare

4-week rank7 / 50

Group average-6.0%

Trend breadth6.0%

Trend6.0%active weekly trend signals

MD18.0%positive activity pressure

RS4.0%positive relative leadership

Four-week leaders

EVGN · TLV18.5%MRHL · TLV9.3%IDNT · TLV8.5%NVLG · TLV7.8%SEMG · TLV7.1%

IndustryIL Biotechnology

4-week rank3 / 14

Group average-5.6%

Trend breadth14.3%

Trend14.3%active weekly trend signals

MD28.6%positive activity pressure

RS7.1%positive relative leadership

Four-week leaders

EVGN · TLV18.5%BLRX · TLV6.7%XTLB · TLV5.3%CGEN · TLV1.1%PPBT · TLV0.0%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape22/100

Trend, activity pressure, participation, and risk combine to a 22/100 tape read.

Indicator analysis29/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.19; 2 reversal markers Next-Week ExpectancyNegative 33.24%

Next-week expectancy is negative with a 33.24% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 11 relevant articles.

Price to earnings forward of XTL Biopharmaceuticals Ltd. – TASE:XTLB Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
31 Jul 2026	0.02 ILA	-4.8%	0.02 ILA	0.05 ILA	1.04	-40.26	2.3M	Off
24 Jul 2026	0.02 ILA	5.0%	0.02 ILA	0.05 ILA	0.97	-40.52	9.9M	Off
17 Jul 2026	0.02 ILA	0.0%	0.02 ILA	0.05 ILA	0.74	-43.70	9.6M	Off
10 Jul 2026	0.02 ILA	5.3%	0.02 ILA	0.05 ILA	0.56	-44.08	23.5M	Off
3 Jul 2026	0.02 ILA	5.6%	0.02 ILA	0.05 ILA	0.33	-49.03	34.1M	Off
26 Jun 2026	0.02 ILA	0.0%	0.02 ILA	0.05 ILA	0.19	-51.42	0	Off
19 Jun 2026	0.02 ILA	5.9%	0.02 ILA	0.05 ILA	0.16	-53.65	22.2K	Off
12 Jun 2026	0.02 ILA	0.0%	0.02 ILA	0.05 ILA	0.18	-59.11	810.6K	Off
5 Jun 2026	0.02 ILA	-5.6%	0.02 ILA	0.05 ILA	0.26	-59.28	13.5M	Off
29 May 2026	0.02 ILA	-5.3%	0.03 ILA	0.05 ILA	0.45	-59.55	12.4M	Off
22 May 2026	0.02 ILA	-5.0%	0.03 ILA	0.05 ILA	0.86	-57.60	19.7M	Off
15 May 2026	0.02 ILA	-4.8%	0.03 ILA	0.05 ILA	0.55	-56.26	20.1M	Off
8 May 2026	0.02 ILA	-32.3%	0.03 ILA	0.05 ILA	0.36	-56.41	40.7M	Off
1 May 2026	0.03 ILA	55.0%	0.03 ILA	0.05 ILA	0.12	-35.83	107.8M	Off

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.